Literature DB >> 10736241

Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.

Q Feng1, Y Liu, K Liu, S Byrne, G Liu, X Wang, Z Li, C D Ockleford.   

Abstract

We have investigated plasmin mediated proteolysis associated with trophoblast invasion during early stages of pregnancy in the rhesus monkey. In situ hybridization and immunocytochemical localization were used to define the cellular and tissue distribution of urokinase plasminogen activator (uPA), plasminogen activator inhibitor type 1 (PAI-1) and 2 (PAI-2) and urokinase receptor in early monkey placenta and uterus. Our results indicate: (1) uPA is expressed in proliferating and invasive cytotrophoblast located in chorionic villi as well as in extravillous trophoblast associated with uterine arterioles. This raises the possibility that urokinase may play an important role in trophoblast invasion. (2) PAI-1 mRNA is specifically localized in two areas where invasive trophoblast cells encounter maternal tissue directly. The extravillous cytotrophoblast cells at the maternofetal junction express PAI-1 mRNA. The invasive endovascular trophoblast cells within the uterine arterioles also express PAI-1 mRNA. The location sensitive expression of PAI-1 mRNA at the maternofetal junction may imply a protective function of this protease inhibitor that might be induced through interaction with decidual cells. (3) Urokinase receptor antigen has also been found at the maternofetal junction and in endovascular trophoblast cells of the invaded maternal blood vessel. (4) PAI-2 immunoreactivity is found in association with cytotrophoblast cells in anchoring choronic villi suggesting its association with early placentation. In conclusion, we propose that the plasmin/plasminogen activator system may not only regulate extracellular matrix degradation, but also modify migration and invasive behaviour of extravillous trophoblast cells, during early placentation. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736241     DOI: 10.1053/plac.1999.0446

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  10 in total

Review 1.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Expression of matrix metalloproteinase-2, tissue inhibitors of metalloproteinase-1, -3 at the implantation site of rhesus monkey during the early stage of pregnancy.

Authors:  F Gao; X L Chen; P Wei; H J Gao; Y X Liu
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

3.  Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.

Authors:  Astrid Dossenbach-Glaninger; Mick van Trotsenburg; Christian Oberkanins; Johanna Atamaniuk
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

4.  Polymorphisms in the MTHFR gene influence embryo viability and the incidence of aneuploidy.

Authors:  María Enciso; Jonás Sarasa; Leoni Xanthopoulou; Sara Bristow; Megan Bowles; Elpida Fragouli; Joy Delhanty; Dagan Wells
Journal:  Hum Genet       Date:  2016-04-11       Impact factor: 4.132

5.  Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7.

Authors:  Xuan Zhang; Etter Hoang; Warren B Nothnick
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

6.  Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.

Authors:  Schu-Rern Chern; Sheng-Hsiang Li; Chung-Hao Lu; Edmund I Tsuen Chen
Journal:  Reprod Biol Endocrinol       Date:  2010-10-27       Impact factor: 5.211

Review 7.  Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Authors:  Yao Ye; Aurelia Vattai; Xi Zhang; Junyan Zhu; Christian J Thaler; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

8.  A complex of novel protease inhibitor, ovostatin homolog, with its cognate proteases in immature mice uterine luminal fluid.

Authors:  Hsien-Lu Huang; Szu-Chin Li; Jin-Fong Wu
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

9.  Immunofluorescence confocal laser scanning microscopy and immuno-electron microscopic identification of keratins in human materno-foetal interaction zone.

Authors:  J Ahenkorah; B Hottor; S Byrne; P Bosio; C D Ockleford
Journal:  J Cell Mol Med       Date:  2008-05-07       Impact factor: 5.310

10.  Hypothesis about Transdifferentiation As Backbone of Malignancy.

Authors:  Jean Piechowski
Journal:  Front Oncol       Date:  2017-06-19       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.